Infertility rates are increasing globally, including in Bangladesh, which has led to a growing demand for in vitro fertilisation (IVF) services. Despite its clinical effectiveness, the high cost of treatment continues to restrict access for many couples. Medical professionals and health policy analysts note that including IVF within health insurance coverage could improve affordability and potentially support more consistent treatment completion.
IVF is an assisted reproductive technology involving several sequential stages. These include ovarian stimulation through medication, retrieval of eggs from the ovaries, fertilisation in a laboratory environment, and subsequent transfer of embryos into the uterus. A standard IVF cycle typically spans two to three weeks. However, medical outcomes often depend on multiple cycles, as success is not guaranteed in a single attempt.
Success rates are strongly influenced by age. Clinical data indicate that women under the age of 35 have an average per-cycle success rate of approximately 50 to 55 per cent. For women aged between 38 and 40, the success rate decreases to around 20 to 30 per cent. Beyond this age range, the likelihood of success continues to decline, reflecting established reproductive medical trends.
The financial burden of IVF remains significant across most regions. In the United States, the cost of one cycle generally ranges between USD 12,000 and USD 30,000, excluding medication and supplementary procedures. In many European countries, costs are comparatively lower but still amount to several thousand euros per cycle. These expenses often lead patients to delay treatment or discontinue it before completing the recommended number of cycles.
Health specialists identify cost as the primary barrier to infertility treatment. Many couples initiate IVF but are unable to complete full treatment plans due to financial constraints. In countries where IVF is covered by insurance systems—either partially or fully—patients are more likely to complete prescribed cycles. Such systems also encourage clinical practices such as limiting the number of embryos transferred, which reduces the risk of multiple pregnancies.
In the United States, insurance coverage for infertility treatment exists in some states, though it is often subject to limitations such as caps on the number of cycles or total expenditure. Several European countries offer broader public healthcare support. For instance, in the Netherlands, up to three IVF or intracytoplasmic sperm injection (ICSI) cycles may be covered under specific eligibility conditions.
In Bangladesh, IVF treatment is largely financed directly by patients. Although private fertility clinics provide advanced services, no standard health insurance policy currently includes IVF coverage. Analysts suggest this reflects both limited innovation in insurance products and relatively low penetration of comprehensive health insurance in the country.
IVF Cost and Coverage Overview
| Region / Country | Cost per IVF Cycle | Insurance Coverage Status | Key Characteristics |
|---|---|---|---|
| United States | USD 12,000–30,000 | Partial (state-dependent) | Coverage varies with restrictions |
| Europe (general) | Several thousand euros | Partial to substantial | Public support in some countries |
| Netherlands | Not uniformly priced | Up to 3 cycles under conditions | Public healthcare inclusion |
| Bangladesh | High relative to income | Not included | Primarily out-of-pocket |
Experts suggest that expanding insurance coverage for IVF could address both accessibility and financial sustainability. It may also contribute to broader insurance market development. As awareness of infertility grows, employers and insurers in various countries are increasingly considering fertility-related benefits as part of wider healthcare packages.